×
About 79,255 results

ALLMedicine™ Gastric Cancer Center

Research & Reviews  38,991 results

Prognosis of hemodialysis patients undergoing surgery for gastric cancer: Results of a ...
https://doi.org/10.1016/j.surg.2021.01.014
Surgery Sugawara K, Yamashita H et. al.

Feb 26th, 2021 - Little is known about the survival outcomes of and predictive factors for survival in hemodialysis patients undergoing surgery for gastric cancer. We performed a multicenter retrospective study from 9 institutions to investigate the survival outco...

Impact of prior cancer history on survival of patients with gastric cancer.
https://doi.org/10.1016/j.ejso.2021.02.007
European Journal of Surgical Oncology : the Journal of Th... Wen L, Yu K et. al.

Feb 26th, 2021 - Patients with prior cancer history are commonly excluded from clinical trial. However, the impact of prior cancer on survival of patients with gastric cancer remains largely unknown. The aim of this study was to evaluate the prevalence of prior ca...

Prognostic Roles of N6-Methyladenosine METTL3 in Different Cancers: A System Review and...
https://doi.org/10.1177/1073274821997455
Cancer Control : Journal of the Moffitt Cancer Center; Liu K, Gao Y et. al.

Feb 26th, 2021 - Recent studies have shown that methyltransferase-like 3, a catalytic enzyme that is predominant in the N6-methyladenosine methyltransferase system, is abnormally expressed in various types of carcinoma and is correlated with poorer prognosis. Howe...

see more →

Guidelines  85 results

Hereditary diffuse gastric cancer: updated clinical practice guidelines.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7116190
The Lancet. Oncology; Blair VR, McLeod M et. al.

Aug 7th, 2020 - Hereditary diffuse gastric cancer (HDGC) is an autosomal dominant cancer syndrome that is characterised by a high prevalence of diffuse gastric cancer and lobular breast cancer. It is largely caused by inactivating germline mutations in the tumour...

Enhertu Impresses in HER2-Positive Gastric Cancer
https://www.medpagetoday.com/meetingcoverage/asco/86766

May 28th, 2020 - Pretreated gastric cancer patients with HER2-positive disease had significantly improved rates of response and survival with trastuzumab deruxtecan (Enhertu) rather than chemotherapy, an open-label phase II trial showed.

Hereditary Cancer Syndromes and Risk Assessment ACOG COMMITTEE OPINION, Number 793
https://journals.lww.com/greenjournal/Fulltext/2019/12000/Hereditary_Cancer_Syndromes_and_Risk_Assessment_.39.aspx
Obstetrics & Gynecology; ACOG

Nov 30th, 2019 - A hereditary cancer syndrome is a genetic predisposition to certain types of cancer, often with onset at an early age, caused by inherited pathogenic variants in one or more genes. Most hereditary cancer syndromes exhibit autosomal dominant inheri...

Hereditary Cancer Syndromes and Risk Assessment: ACOG COMMITTEE OPINION, Number 793.
https://doi.org/10.1097/AOG.0000000000003562
Obstetrics and Gynecology;

Nov 25th, 2019 - A hereditary cancer syndrome is a genetic predisposition to certain types of cancer, often with onset at an early age, caused by inherited pathogenic variants in one or more genes. Most hereditary cancer syndromes exhibit autosomal dominant inheri...

Gastric Cancer Treatment (PDQ®)–Health Professional Version Go to Patient Version
https://www.cancer.gov/types/stomach/hp/stomach-treatment-pdq

Oct 10th, 2019 - Gastric cancer treatment options depend on extent of disease and may include radical surgery, chemotherapy, radiation, and immunotherapy. Get detailed information about the diagnosis, treatment, and prognosis of newly diagnosed and recurrent gastr...

see more →

Drugs  4 results see all →

Clinicaltrials.gov  39,585 results

Prognosis of hemodialysis patients undergoing surgery for gastric cancer: Results of a ...
https://doi.org/10.1016/j.surg.2021.01.014
Surgery Sugawara K, Yamashita H et. al.

Feb 26th, 2021 - Little is known about the survival outcomes of and predictive factors for survival in hemodialysis patients undergoing surgery for gastric cancer. We performed a multicenter retrospective study from 9 institutions to investigate the survival outco...

Impact of prior cancer history on survival of patients with gastric cancer.
https://doi.org/10.1016/j.ejso.2021.02.007
European Journal of Surgical Oncology : the Journal of Th... Wen L, Yu K et. al.

Feb 26th, 2021 - Patients with prior cancer history are commonly excluded from clinical trial. However, the impact of prior cancer on survival of patients with gastric cancer remains largely unknown. The aim of this study was to evaluate the prevalence of prior ca...

Prognostic Roles of N6-Methyladenosine METTL3 in Different Cancers: A System Review and...
https://doi.org/10.1177/1073274821997455
Cancer Control : Journal of the Moffitt Cancer Center; Liu K, Gao Y et. al.

Feb 26th, 2021 - Recent studies have shown that methyltransferase-like 3, a catalytic enzyme that is predominant in the N6-methyladenosine methyltransferase system, is abnormally expressed in various types of carcinoma and is correlated with poorer prognosis. Howe...

see more →

News  587 results

Robotic Total Gastrectomy Pricier, but Has Some Advantages Over Traditional Laparoscopic Approach
https://www.medscape.com/viewarticle/945834

Feb 15th, 2021 - NEW YORK (Reuters Health) - In experienced hands, robotic total gastrectomy has advantages for the surgeon and patient, but is costlier than traditional laparoscopic surgery, according to a study from China. The study showed that "in complex, mini...

Better Survival With S-1/Docetaxel in Stage III Gastric Cancer
https://www.medscape.com/viewarticle/944265

Jan 17th, 2021 - A new recommendation for the treatment of patients with gastric cancer has been proposed on the basis of final results from the phase 3 trial GC-07, which showed survival benefit. The trial was conducted by the Japan Clinical Cancer Research Organ...

Gut Microbiome Predicts Nivolumab Efficacy in Gastric Cancer?
https://www.medscape.com/viewarticle/944261

Jan 17th, 2021 - Preliminary data suggest that a certain pattern of gut microbes may be useful in predicting which patients with advanced gastric cancer are likely to benefit from treatment with the immunotherapy nivolumab (Opdivo). Researchers have demonstrated b...

H Pylori Eradication Testing Less Likely in Black Patients
https://www.medscape.com/viewarticle/940437

Nov 4th, 2020 - Black patients may be significantly less likely to receive eradication testing after treatment for Helicobacter pylori infection than patients of other races/ethnic groups, based on a retrospective analysis of more than 1,700 individuals. This dis...

'Paradigm Shift' in Gastric Junction Cancers With Nivolumab
https://www.medscape.com/viewarticle/937916

Sep 22nd, 2020 - Patients with gastric cancer or gastroesophageal junction cancer (GEJ) could experience significantly improved progression-free survival, and maybe also overall survival, with nivolumab (Opdivo) in the first-line and neoadjuvant settings, suggest ...

see more →

Patient Education  3 results see all →